HomeCompareKPCPY vs JNJ

KPCPY vs JNJ: Dividend Comparison 2026

KPCPY yields 6.34% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KPCPY wins by $24467.18M in total portfolio value
10 years
KPCPY
KPCPY
● Live price
6.34%
Share price
$23.35
Annual div
$1.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24467.21M
Annual income
$23,747,459,833.29
Full KPCPY calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — KPCPY vs JNJ

📍 KPCPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKPCPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KPCPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KPCPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KPCPY
Annual income on $10K today (after 15% tax)
$538.76/yr
After 10yr DRIP, annual income (after tax)
$20,185,340,858.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, KPCPY beats the other by $20,185,336,820.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KPCPY + JNJ for your $10,000?

KPCPY: 50%JNJ: 50%
100% JNJ50/50100% KPCPY
Portfolio after 10yr
$12233.62M
Annual income
$11,873,732,291.59/yr
Blended yield
97.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KPCPY
No analyst data
Altman Z
0.4
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KPCPY buys
0
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Sheri Biggs🏢 House$KPCPY▼ Sell$1,001 - $15,0002025-03-18
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKPCPYJNJ
Forward yield6.34%2.14%
Annual dividend / share$1.48$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$24467.21M$30.5K
Annual income after 10y$23,747,459,833.29$4,749.88
Total dividends collected$24417.49M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KPCPY vs JNJ ($10,000, DRIP)

YearKPCPY PortfolioKPCPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,968$1,267.67$10,594$274.49+$1.4KKPCPY
2$15,641$2,835.70$11,294$360.69+$4.3KKPCPY
3$23,663$6,927.31$12,133$476.91+$11.5KKPCPY
4$44,909$19,589.29$13,156$635.42+$31.8KKPCPY
5$117,543$69,490.14$14,432$854.61+$103.1KKPCPY
6$465,734$339,963.17$16,056$1,162.76+$449.7KKPCPY
7$3,016,128$2,517,793.03$18,175$1,604.53+$3.00MKPCPY
8$33,704,675$30,477,418.00$21,009$2,252.68+$33.68MKPCPY
9$672,661,194$636,597,191.33$24,911$3,229.73+$672.64MKPCPY
10$24,467,207,311$23,747,459,833.29$30,458$4,749.88+$24467.18MKPCPY

KPCPY vs JNJ: Complete Analysis 2026

KPCPYStock

Kasikornbank Public Company Limited, together with its subsidiaries, provides commercial banking products and services in Thailand and internationally. The company's personal banking products and services include savings, current, fixed deposit, and foreign currency accounts; personal, home, and auto loans; debit and credit cards; life and non-life insurance products; investment products, such as mutual funds, stocks, and derivatives/futures exchange; money transfer and bill payment, cheque and draft, and foreign exchange services; and digital banking services. It also offers various products and services for small and medium enterprises, including savings, current, and fixed deposits; working capital, commercial, and special loans, as well as letters of guarantee; collection and payment services; life, non-life, and group insurance products; and import, export, and money transfer services. In addition, the company provides various products and services for corporate customers, such as cash management solutions, including current, savings, special savings deposit, and fixed deposit accounts, as well as collection, payment, liquidity management, and electronic service solutions; international trade solutions comprising import and export, global money transfer, guarantee, and trade finance solutions; working capital loans, term loans, special loans, and letters of guarantee; supply chain financing; life, non-life, and group insurance products; and foreign exchange and derivatives, corporate finance, securities, investment, and business card services. Further, it offers auto and equipment leasing, and venture capital management services. The company operates 839 branches. Kasikornbank Public Company Limited was founded in 1945 and is headquartered in Bangkok, Thailand.

Full KPCPY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this KPCPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KPCPY vs SCHDKPCPY vs JEPIKPCPY vs OKPCPY vs KOKPCPY vs MAINKPCPY vs ABBVKPCPY vs MRKKPCPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.